Brain Cancer - Bennett Cancer Center - Stamford Health

Brain Cancer

Questions About Brain Cancer?

We’re here to help. Contact our Oncology Nurse Navigator, Alison Behm, RN, OCN, at 203-276-CARE. Press 1.

Our multi-disciplinary team approach at the Bennett Cancer Center is vital to optimally treating and managing patients with the full spectrum of both benign and malignant brain tumors and is always inspired by the Planetree philosophy of putting you—our patient—first.

In 2016, the Bennett Cancer Center and Stamford Hospital partnered with the Dana Farber Cancer Institute (DFCI)/Brigham and Women’s Hospital in Boston as a member of the Cancer Care Collaborative. These initiatives, in conjunction with the Bennett Cancer Center’s longstanding membership in the Eastern Cooperative Oncology Group (ECOG), continue to assure that the neurooncology program at the Bennett Cancer Center and Stamford Hospital will be able to provide cutting edge clinical research studies generally available only at academic centers to patients in Fairfield County and Westchester County.

Brain Cancer Treatment Options

The neurooncology program at the Bennett Cancer Center’s leverage is the expertise of its multidisciplinary team to offer the most advanced brain cancer treatments, both as individual interventions and as part of a multifaceted treatment approach, including:

  • CyberKnife® radiosurgery and treatments that target brain tumors with pinpoint accuracy while delivering enhanced doses of radiation therapy to both improve efficacy and minimize toxicity. All of these benefits are accomplished without the need to surgically insert stabilizing devices into the skull.
  • Standard radiation therapy
  • Traditional and minimally invasive neurosurgical interventions and procedures
  • State-of-the-art chemotherapy and biologic therapies
  • Cutting edge clinical research protocols as well as individualized targeted therapies available through innovative, personalized-medicine collaborative research programs. These programs utilize the latest molecular medicine tools, including next-generation sequencing (NGS) of the individual tumor DNA.